<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33672">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668250</url>
  </required_header>
  <id_info>
    <org_study_id>1508190</org_study_id>
    <nct_id>NCT02668250</nct_id>
  </id_info>
  <brief_title>Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality</brief_title>
  <acronym>OPTI-AGED</acronym>
  <official_title>The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the increasing aging population demographics and life expectancies, the number of very
      elderly patients undergoing surgery is rising. Elderly patients constitute an increasingly
      large proportion of the high-risk surgical group.

      Cardiac complications and postoperative pulmonary complications are equally prevalent and
      contribute similarly to morbidity, mortality, and length of hospital stay. Specific
      optimization strategy of general anesthesia has been tested in high-risk patients undergoing
      major surgery to improve outcomes.

      Our hypothesis is that a combined optimization strategy of anesthesia concerning
      hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome
      in elderly undergoing high risk surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The population is expanding and aging. With the increasing aging population demographics and
      life expectancies, the number of very elderly patients (age â‰¥ 80) undergoing surgery is
      rising. Elderly patients constitute an increasingly large proportion of the high-risk
      surgical group. In 2010, patients aged 80 yrs and over represented only 2.1% of patients
      undergoing high risk surgery in France (PMSI database), but concentrated 27% of in-hospital
      deaths.

      Cardiac complications and postoperative pulmonary complications are equally prevalent and
      contribute similarly to morbidity, mortality, and length of hospital stay. Specific
      optimization strategy of general anesthesia has been tested in high-risk patients undergoing
      major surgery to improve outcomes. Meta-analyses have demonstrated that goal directed
      hemodynamic therapy significantly reduced mortality and surgical complications in high-risk
      patients. A lung-protective ventilation strategy in high-risk patients undergoing major
      abdominal surgery was associated with improved clinical outcome. Retrospective studies
      indicated that a combination of excessive depth of anesthesia, hypotension and low
      anesthesia requirement resulted in increased mortality. These approaches of peroperative
      care remain discussed in the literature and have also to be incorporated in the common
      clinical practice. Moreover, few of these reviews performed a sensitive analysis in the
      elderly.

      Whether a multi-parametric optimization strategy of anesthesia including several specific
      interventions will impact the short-term postoperative major morbidity and mortality in
      elderly is not known. The addition of depth of anesthesia monitoring to hemodynamic
      monitoring and goal directed hemodynamic therapy may improve tissue perfusion by reducing
      hemodynamic side effects of anesthetic agents, particularly in elderly where the therapeutic
      window of these agents is reduced. The effects of low protective ventilation may also by
      additive to the previous measures by reducing the perioperative build-up of oxygen debt. Our
      hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic,
      ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly
      undergoing high risk surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2017</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of a major postoperative complication.</measure>
    <time_frame>Day 30</time_frame>
    <description>Major postoperative complications (acute kidney injury, acute myocardial infarction, heart failure, stroke, severe sepsis, septic shock, acute respiratory failure requiring noninvasive ventilation or intubation, delirium) will be reported in the source folder of the patients, and the mortality will be also focused. The goal of this study is to decrease this incidence.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Coronary; Ischemic</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <condition>Heart Failure</condition>
  <condition>Peripheral Vascular Diseases</condition>
  <condition>Dementia</condition>
  <condition>Stroke</condition>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Alcoholism</condition>
  <condition>Cancer</condition>
  <condition>Diabetes</condition>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Experimental group : OPTI-AGED</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The OPTI-AGED group will receive a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group :</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will not benefit from the OPTI-AGED intervention but patients will receive the usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OPTI-AGED</intervention_name>
    <description>OPTI-AGED is composed of a multi-parametric optimization strategy.</description>
    <arm_group_label>Experimental group : OPTI-AGED</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Patients receive the usual care.</description>
    <arm_group_label>Control Group :</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients aged 80 years and over,

          -  presenting at least one of the following comorbidities: ischemic coronary disease;
             cardiac arrhythmia; congestive heart failure; peripheral vascular disease; dementia;
             stroke; chronic obstructive pulmonary disease; chronic respiratory failure; chronic
             alcohol abuse; active cancer; diabetes; chronic renal failure A comorbidity index
             will be measured by using the modified Charlson Comorbidity Index

          -  undergoing elective and emergency surgeries including : femoral head fracture, major
             intraperitoneal abdominal surgery lasting &gt; 90 min (excluding elective
             cholecystectomy, abdominal wall surgery), vascular surgery (excluding venous surgery
             and fistula creation)

          -  Patient's or patient's relative signed consent form

          -  Affiliation to French social assurance system

        Exclusion Criteria:

          -  Acute heart failure and acute coronary syndrome

          -  Acute respiratory failure, pneumonia

          -  Septic shock

          -  Delirium

          -  Acute stroke

          -  Evolutive neuromuscular disorder

          -  Thoracic surgery, combined abdominal and thoracic surgery

          -  Surgery performed under exclusive regional anesthesia

          -  Patients under tutorship or curatorship

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>80 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MOLLIEX Serge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MOLLIEX Serge, MD</last_name>
    <phone>(0)477120922</phone>
    <phone_ext>+33</phone_ext>
    <email>serge.molliex@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LABRUYERE Carine, CRA</last_name>
    <phone>(0)477120469</phone>
    <phone_ext>+33</phone_ext>
    <email>carine.labruyere@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BIAIS Mathieu, MD</last_name>
    </contact>
    <investigator>
      <last_name>BIAIS Mathieu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>SZTARK FranÃ§ois, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU CAEN</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>HANOUZ Jean-Luc, MD</last_name>
    </contact>
    <investigator>
      <last_name>HANOUZ Jean-Luc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CONSTANTIN Jean-Michel, MD</last_name>
    </contact>
    <investigator>
      <last_name>CONSTANTIN Jean-Michel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>FUTIER Emmanuel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>GIGARD Claude, MD</last_name>
    </contact>
    <investigator>
      <last_name>GIGARD Claude, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Grenoble</name>
      <address>
        <city>Grenoble 9</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ALBALADEJO Pierre, MD</last_name>
    </contact>
    <investigator>
      <last_name>ALBALADEJO Pierre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>BOUZAT Pierre, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LEBUFFE Gilles, MD</last_name>
    </contact>
    <investigator>
      <last_name>LEBUFFE Gilles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>TAVERNIER BenoÃ®t, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU LYON</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>AUBRUN FrÃ©dÃ©ric, MD</last_name>
    </contact>
    <investigator>
      <last_name>AUBRUN FrÃ©dÃ©ric, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>RIMMELE Thomas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PIRIOU Vincent, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Marseille La Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BRUDER Nicolas, MD</last_name>
    </contact>
    <investigator>
      <last_name>BRUDER Nicolas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Marseille Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LEONE Marc, MD</last_name>
    </contact>
    <investigator>
      <last_name>LEONE Marc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Montpellier</name>
      <address>
        <city>Montpellier 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>JABER Samir, MD</last_name>
    </contact>
    <investigator>
      <last_name>JABER Samir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MEISTELMAN Claude, MD</last_name>
    </contact>
    <investigator>
      <last_name>MEISTELMAN Claude, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU NICE</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CARLES Michel, MD</last_name>
    </contact>
    <investigator>
      <last_name>CARLES Michel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Nimes</name>
      <address>
        <city>NÃ®mes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LEFRANT Jean-Yves, MD</last_name>
    </contact>
    <investigator>
      <last_name>LEFRANT Jean-Yves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>RIPART Jacques, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Paris Beaujon</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PAUGAM Catherine, MD</last_name>
    </contact>
    <investigator>
      <last_name>PAUGAM Catherine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Paris Bichat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MONTRAVERS Philippe, MD</last_name>
    </contact>
    <investigator>
      <last_name>MONTRAVERS Philippe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Paris Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LANGERON Olivier, MD</last_name>
    </contact>
    <investigator>
      <last_name>LANGERON Olivier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>RAUX Mathieu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Paris Saint Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BEAUSSIER Marc, MD</last_name>
    </contact>
    <investigator>
      <last_name>BEAUSSIER Marc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Saint Louis-Lariboisiere</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PLAUD Benoit, MD</last_name>
    </contact>
    <investigator>
      <last_name>PLAUD BenoÃ®t, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>DEBAENE Bertrand, MD</last_name>
      <phone>0549444444</phone>
    </contact>
    <investigator>
      <last_name>DEBAENE Bertrand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BELOEIL HÃ©lÃ¨ne, MD</last_name>
    </contact>
    <investigator>
      <last_name>BELOEIL HÃ©lÃ¨ne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>DUREUIL Bertrand, MD</last_name>
      <phone>0232888990</phone>
    </contact>
    <investigator>
      <last_name>DUREUIL Bertrand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>COMPERE Vincent, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MOLLIEX Serge, MD</last_name>
    </contact>
    <investigator>
      <last_name>MOLLIEX Serge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Central Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MERTES Michel, MD</last_name>
    </contact>
    <investigator>
      <last_name>MERTES Michel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>STEIB Annick, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Hautepierre Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>DIEMUNSCH Pierre, MD</last_name>
    </contact>
    <investigator>
      <last_name>DIEMUNSCH Pierre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Toulouse</name>
      <address>
        <city>Toulouse 9</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MINVILLE Vincent, MD</last_name>
      <phone>0561778233</phone>
    </contact>
    <investigator>
      <last_name>MINVILLE Vincent, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 12, 2017</lastchanged_date>
  <firstreceived_date>January 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
